Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors

por Cives, Mauro, Pelle’, Eleonora, Strosberg, Jonathan
Publicado 2020

What is the role of checkpoint inhibitors in neuroendocrine neoplasms?

por Al-Toubah, Taymeyah, Pelle, Eleonora, Strosberg, Jonathan
Publicado 2020

pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo

por Cafforio, Paola, Viggiano, Luigi, Mannavola, Francesco, Pellè, Eleonora, Caporusso, Concetta, Maiorano, Eugenio, Felici, Claudia, Silvestris, Francesco
Publicado 2017

Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology

por Palmirotta, Raffaele, Lovero, Domenica, Cafforio, Paola, Felici, Claudia, Mannavola, Francesco, Pellè, Eleonora, Quaresmini, Davide, Tucci, Marco, Silvestris, Franco
Publicado 2018

DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors

por Cives, Mauro, Partelli, Stefano, Palmirotta, Raffaele, Lovero, Domenica, Mandriani, Barbara, Quaresmini, Davide, Pelle’, Eleonora, Andreasi, Valentina, Castelli, Paola, Strosberg, Jonathan, Zamboni, Giuseppe, Falconi, Massimo, Silvestris, Franco
Publicado 2019

Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors

por Mandriani, Barbara, Pellè, Eleonora, Mannavola, Francesco, Palazzo, Antonio, Marsano, Renè Massimiliano, Ingravallo, Giuseppe, Cazzato, Gerardo, Ramello, Maria Cecilia, Porta, Camillo, Strosberg, Jonathan, Abate-Daga, Daniel, Cives, Mauro
Publicado 2022